Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit A5 pseudogene 5 (NDUFA5P5)
- Target
- NDUFA5P5
- Molecular classification
- Pseudogene
01
Overview
NADH:ubiquinone oxidoreductase subunit A5 pseudogene 5 (NDUFA5P5) is classified as a pseudogene, originating from the protein-coding gene encoding a subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), but has lost its ability to encode a functional protein. Pseudogenes are often considered non-functional remnants of duplicated or retrotransposed genes, although some have regulatory roles, such as acting as RNA decoys or being transcribed into noncoding RNAs that modulate expression of related genes. NDUFA5P5 does not have a documented protein product, biological activity, or established involvement in any direct disease pathogenesis or drug targeting. It is not considered a therapeutic target or a functional receptor/enzyme/transporter.
02
Mechanism of action
None (pseudogene; not a druggable protein or functional enzyme/receptor)
03
Biological functions
May participate in regulation of gene expression as a noncoding RNA, potentially by acting as a microRNA decoy or forming regulatory RNAs
04
Disease associations
Other (Some pseudogenes have been implicated in cancer and other diseases by regulating parental genes, but specific evidence for NDUFA5P5 is lacking)
Beyond the preview
Go deeper on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 5 (NDUFA5P5).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 5 (NDUFA5P5).